79 related articles for article (PubMed ID: 34938774)
1. Integrative analysis of metabolism subtypes and identification of prognostic metabolism-related genes for glioblastoma.
Li J; Wei Y; Liu J; Cheng S; Zhang X; Qiu H; Li J; He C
Biosci Rep; 2024 Mar; 44(3):. PubMed ID: 38419527
[TBL] [Abstract][Full Text] [Related]
2. Correlations between stemness indices for hepatocellular carcinoma, clinical characteristics, and prognosis.
Li J; Zhang C; Yuan X; Ren Z; Yu Z
Am J Transl Res; 2020; 12(9):5496-5510. PubMed ID: 33042433
[TBL] [Abstract][Full Text] [Related]
3. Development of a stemness-related prognostic index to provide therapeutic strategies for bladder cancer.
Fu S; Tan Z; Shi H; Chen J; Zhang Y; Guo C; Feng W; Xu H; Wang J; Wang H
NPJ Precis Oncol; 2024 Jan; 8(1):14. PubMed ID: 38245587
[TBL] [Abstract][Full Text] [Related]
4. Radiomic model to predict the expression of PD-1 and overall survival of patients with ovarian cancer.
Gao L; Jiang W; Yue Q; Ye R; Li Y; Hong J; Zhang M
Int Immunopharmacol; 2022 Dec; 113(Pt A):109335. PubMed ID: 36279669
[TBL] [Abstract][Full Text] [Related]
5. A novel prognostic signature based on cancer stemness and metabolism-related genes for cervical squamous cell carcinoma and endocervical adenocarcinoma.
Wang Y; Han Y; Jin L; Ji L; Liu Y; Lin M; Zhou S; Yang R
Aging (Albany NY); 2024 Apr; 16(8):7293-7310. PubMed ID: 38656879
[TBL] [Abstract][Full Text] [Related]
6. Discovery and identification of the prognostic significance and potential mechanism of FMO2 in breast cancer.
Wu L; Chu J; Shangguan L; Cao M; Lu F
Aging (Albany NY); 2023 Nov; 15(21):12651-12673. PubMed ID: 37963835
[TBL] [Abstract][Full Text] [Related]
7. Construction and Validation of a Prognostic Model Based on mRNAsi-Related Genes in Breast Cancer.
Zhao X; Lin J
Comput Math Methods Med; 2022; 2022():6532591. PubMed ID: 36267313
[TBL] [Abstract][Full Text] [Related]
8. Metabolic pathway-based molecular subtyping of colon cancer reveals clinical immunotherapy potential and prognosis.
Dai Z; Peng X; Guo Y; Shen X; Ding W; Fu J; Liang Z; Song J
J Cancer Res Clin Oncol; 2023 Jun; 149(6):2393-2416. PubMed ID: 35731273
[TBL] [Abstract][Full Text] [Related]
9. Development and validation of a hypoxia-stemness-based prognostic signature in pancreatic adenocarcinoma.
Tian X; Zheng J; Mou W; Lu G; Chen S; Du J; Zheng Y; Chen S; Shen B; Li J; Wang N
Front Pharmacol; 2022; 13():939542. PubMed ID: 35935823
[No Abstract] [Full Text] [Related]
10. Prognostic Value of mRNAsi/Corrected mRNAsi Calculated by the One-Class Logistic Regression Machine-Learning Algorithm in Glioblastoma Within Multiple Datasets.
Zhang M; Chen H; Liang B; Wang X; Gu N; Xue F; Yue Q; Zhang Q; Hong J
Front Mol Biosci; 2021; 8():777921. PubMed ID: 34938774
[TBL] [Abstract][Full Text] [Related]
11. Machine learning revealed stemness features and a novel stemness-based classification with appealing implications in discriminating the prognosis, immunotherapy and temozolomide responses of 906 glioblastoma patients.
Wang Z; Wang Y; Yang T; Xing H; Wang Y; Gao L; Guo X; Xing B; Wang Y; Ma W
Brief Bioinform; 2021 Sep; 22(5):. PubMed ID: 33839757
[TBL] [Abstract][Full Text] [Related]
12. Integrative stemness characteristics associated with prognosis and the immune microenvironment in esophageal cancer.
Yi L; Huang P; Zou X; Guo L; Gu Y; Wen C; Wu G
Pharmacol Res; 2020 Nov; 161():105144. PubMed ID: 32810627
[TBL] [Abstract][Full Text] [Related]
13. Identification of Prognostic Model and Biomarkers for Cancer Stem Cell Characteristics in Glioblastoma by Network Analysis of Multi-Omics Data and Stemness Indices.
Du J; Yan X; Mi S; Li Y; Ji H; Hou K; Ma S; Ba Y; Zhou P; Chen L; Xie R; Hu S
Front Cell Dev Biol; 2020; 8():558961. PubMed ID: 33195193
[TBL] [Abstract][Full Text] [Related]
14. Integrative Analysis of Gene Expression Through One-Class Logistic Regression Machine Learning Identifies Stemness Features in Multiple Myeloma.
Ban C; Yang F; Wei M; Liu Q; Wang J; Chen L; Lu L; Xie D; Liu L; Huang J
Front Genet; 2021; 12():666561. PubMed ID: 34484287
[TBL] [Abstract][Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
